(1)
Efficacy of Apremilast on Quality-of-Life Measures in Patients With Moderate Plaque Psoriasis (UNVEIL Phase IV Study). J of Skin 2017, 1 (3.1), s13. https://doi.org/10.25251/skin.1.supp.12.